

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 8.78553280 |
| 2 | angiotensin maturation (GO:0002003) | 8.55499383 |
| 3 | antibacterial humoral response (GO:0019731) | 7.48027664 |
| 4 | antimicrobial humoral response (GO:0019730) | 7.27012874 |
| 5 | regulation of cellular extravasation (GO:0002691) | 7.09874805 |
| 6 | glomerular filtration (GO:0003094) | 7.07062532 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.94469004 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.94469004 |
| 9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.86236446 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.47336213 |
| 11 | renal filtration (GO:0097205) | 6.33237020 |
| 12 | complement activation, classical pathway (GO:0006958) | 6.32384257 |
| 13 | intestinal absorption (GO:0050892) | 6.22298906 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.08668259 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.08668259 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 6.08668259 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 6.08668259 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 6.08668259 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.08668259 |
| 20 | cellular response to type I interferon (GO:0071357) | 5.88863103 |
| 21 | type I interferon signaling pathway (GO:0060337) | 5.88863103 |
| 22 | response to type I interferon (GO:0034340) | 5.86719766 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 5.51875896 |
| 24 | regulation of respiratory burst (GO:0060263) | 5.43678384 |
| 25 | positive regulation of pseudopodium assembly (GO:0031274) | 5.35945109 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 5.32202222 |
| 27 | complement activation (GO:0006956) | 4.94744945 |
| 28 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.92979569 |
| 29 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.81425563 |
| 30 | NADH metabolic process (GO:0006734) | 4.79549389 |
| 31 | regulation of pseudopodium assembly (GO:0031272) | 4.78763924 |
| 32 | negative regulation of viral genome replication (GO:0045071) | 4.75947195 |
| 33 | response to interferon-alpha (GO:0035455) | 4.66963502 |
| 34 | urea cycle (GO:0000050) | 4.66156354 |
| 35 | oligosaccharide biosynthetic process (GO:0009312) | 4.56286049 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 4.55937677 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.55530744 |
| 38 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.54406707 |
| 39 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.54406707 |
| 40 | endocrine process (GO:0050886) | 4.54406707 |
| 41 | regulation of bile acid biosynthetic process (GO:0070857) | 4.39772211 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.38454201 |
| 43 | regulation of RIG-I signaling pathway (GO:0039535) | 4.37717776 |
| 44 | urea metabolic process (GO:0019627) | 4.32410797 |
| 45 | cellular response to interferon-alpha (GO:0035457) | 4.31480047 |
| 46 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.31294127 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30588843 |
| 48 | response to peptidoglycan (GO:0032494) | 4.29724417 |
| 49 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.29672819 |
| 50 | positive regulation of type 2 immune response (GO:0002830) | 4.24705458 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.23858566 |
| 52 | natural killer cell mediated immunity (GO:0002228) | 4.23858566 |
| 53 | regulation of systemic arterial blood pressure (GO:0003073) | 4.23267346 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 4.21293427 |
| 55 | response to host immune response (GO:0052572) | 4.17320146 |
| 56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17320146 |
| 57 | midgut development (GO:0007494) | 4.16960439 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.08953387 |
| 59 | lipoprotein transport (GO:0042953) | 4.08266615 |
| 60 | * regulation of guanylate cyclase activity (GO:0031282) | 4.02791235 |
| 61 | positive regulation of heat generation (GO:0031652) | 4.02218950 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 4.00410192 |
| 63 | hormone catabolic process (GO:0042447) | 3.95623080 |
| 64 | adhesion of symbiont to host cell (GO:0044650) | 3.94822617 |
| 65 | virion attachment to host cell (GO:0019062) | 3.94822617 |
| 66 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.93364063 |
| 67 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.92563951 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 3.92419776 |
| 69 | positive regulation of interferon-beta production (GO:0032728) | 3.90728372 |
| 70 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.89927186 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 3.85833857 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.84473018 |
| 73 | T-helper 1 type immune response (GO:0042088) | 3.84386092 |
| 74 | diacylglycerol metabolic process (GO:0046339) | 3.83067393 |
| 75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.75084645 |
| 76 | regulation of fever generation (GO:0031620) | 3.74831631 |
| 77 | epithelial structure maintenance (GO:0010669) | 3.73655208 |
| 78 | response to host defenses (GO:0052200) | 3.73514500 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.73514500 |
| 80 | response to host (GO:0075136) | 3.73514500 |
| 81 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.72464061 |
| 82 | O-glycan processing (GO:0016266) | 3.70116105 |
| 83 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.69949811 |
| 84 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.69741086 |
| 85 | fructose metabolic process (GO:0006000) | 3.69015188 |
| 86 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.65667709 |
| 87 | GDP-mannose metabolic process (GO:0019673) | 3.65160583 |
| 88 | cellular response to virus (GO:0098586) | 3.64730934 |
| 89 | respiratory burst (GO:0045730) | 3.63994221 |
| 90 | protein activation cascade (GO:0072376) | 3.63898734 |
| 91 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.63120693 |
| 92 | epoxygenase P450 pathway (GO:0019373) | 3.62274863 |
| 93 | peptide hormone processing (GO:0016486) | 3.61705663 |
| 94 | ethanol oxidation (GO:0006069) | 3.61608294 |
| 95 | response to muramyl dipeptide (GO:0032495) | 3.61540357 |
| 96 | lymphocyte chemotaxis (GO:0048247) | 3.58799069 |
| 97 | renal system process involved in regulation of blood volume (GO:0001977) | 3.57846891 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 3.56641772 |
| 99 | regulation of vitamin metabolic process (GO:0030656) | 3.55524365 |
| 100 | * cellular response to interferon-gamma (GO:0071346) | 3.53821832 |
| 101 | defense response to protozoan (GO:0042832) | 3.52819604 |
| 102 | eosinophil chemotaxis (GO:0048245) | 3.52463961 |
| 103 | peptide catabolic process (GO:0043171) | 3.52319783 |
| 104 | humoral immune response (GO:0006959) | 3.47102225 |
| 105 | fucosylation (GO:0036065) | 3.43736920 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 3.43585721 |
| 107 | defense response to virus (GO:0051607) | 3.43396191 |
| 108 | digestive system process (GO:0022600) | 3.43159435 |
| 109 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43107317 |
| 110 | regulation of chemokine biosynthetic process (GO:0045073) | 3.40750937 |
| 111 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.40413495 |
| 112 | positive regulation of T cell cytokine production (GO:0002726) | 3.39826677 |
| 113 | response to interferon-beta (GO:0035456) | 3.39249273 |
| 114 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.39170262 |
| 115 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.38649582 |
| 116 | regulation of podosome assembly (GO:0071801) | 3.37536498 |
| 117 | glycolipid catabolic process (GO:0019377) | 3.37280271 |
| 118 | microglial cell activation (GO:0001774) | 3.37276204 |
| 119 | cellular response to interferon-beta (GO:0035458) | 3.36606211 |
| 120 | positive regulation of interleukin-12 production (GO:0032735) | 3.35747855 |
| 121 | low-density lipoprotein particle remodeling (GO:0034374) | 3.35373645 |
| 122 | glycosphingolipid catabolic process (GO:0046479) | 3.34001790 |
| 123 | vitamin A metabolic process (GO:0006776) | 3.33869117 |
| 124 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.33391432 |
| 125 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32668464 |
| 126 | auditory receptor cell differentiation (GO:0042491) | 3.32269521 |
| 127 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.32268538 |
| 128 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.31983596 |
| 129 | NIK/NF-kappaB signaling (GO:0038061) | 3.31144383 |
| 130 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.31052548 |
| 131 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.31021675 |
| 132 | uronic acid metabolic process (GO:0006063) | 3.30248158 |
| 133 | glucuronate metabolic process (GO:0019585) | 3.30248158 |
| 134 | adhesion of symbiont to host (GO:0044406) | 3.29098175 |
| 135 | * response to interferon-gamma (GO:0034341) | 3.27282404 |
| 136 | cellular glucuronidation (GO:0052695) | 3.23804498 |
| 137 | regulation of toll-like receptor signaling pathway (GO:0034121) | 3.18731449 |
| 138 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.18727564 |
| 139 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.18372571 |
| 140 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.17950824 |
| 141 | macrophage activation (GO:0042116) | 3.17146302 |
| 142 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.14638439 |
| 143 | cGMP-mediated signaling (GO:0019934) | 3.13952953 |
| 144 | granulocyte activation (GO:0036230) | 3.13781882 |
| 145 | transcytosis (GO:0045056) | 3.13323926 |
| 146 | eosinophil migration (GO:0072677) | 3.11362364 |
| 147 | myeloid dendritic cell differentiation (GO:0043011) | 3.11206845 |
| 148 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.10259817 |
| 149 | B cell mediated immunity (GO:0019724) | 3.07724415 |
| 150 | response to protozoan (GO:0001562) | 3.07267641 |
| 151 | positive regulation of interleukin-17 production (GO:0032740) | 3.06786733 |
| 152 | positive regulation of response to biotic stimulus (GO:0002833) | 3.04128158 |
| 153 | intracellular pH reduction (GO:0051452) | 3.03131180 |
| 154 | cellular response to exogenous dsRNA (GO:0071360) | 3.02054054 |
| 155 | execution phase of apoptosis (GO:0097194) | 2.99991604 |
| 156 | I-kappaB phosphorylation (GO:0007252) | 2.99645013 |
| 157 | sexual reproduction (GO:0019953) | 2.99636691 |
| 158 | regulation of heat generation (GO:0031650) | 2.99143624 |
| 159 | digestion (GO:0007586) | 2.98342614 |
| 160 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.97518099 |
| 161 | negative regulation of viral process (GO:0048525) | 2.95177269 |
| 162 | T cell migration (GO:0072678) | 2.92730801 |
| 163 | retina homeostasis (GO:0001895) | 2.91872196 |
| 164 | myeloid cell activation involved in immune response (GO:0002275) | 2.90994961 |
| 165 | reactive oxygen species biosynthetic process (GO:1903409) | 2.89174179 |
| 166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88785098 |
| 167 | regulation of cholesterol storage (GO:0010885) | 2.88777067 |
| 168 | regulation of mononuclear cell migration (GO:0071675) | 2.88702549 |
| 169 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.88515139 |
| 170 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.86735928 |
| 171 | drug metabolic process (GO:0017144) | 2.86594995 |
| 172 | labyrinthine layer development (GO:0060711) | 2.86236976 |
| 173 | regulation of interferon-beta production (GO:0032648) | 2.86210208 |
| 174 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.85003480 |
| 175 | neutrophil activation (GO:0042119) | 2.84649627 |
| 176 | leukocyte mediated cytotoxicity (GO:0001909) | 2.84115416 |
| 177 | glomerulus development (GO:0032835) | 2.83662118 |
| 178 | negative regulation of epidermis development (GO:0045683) | 2.81766773 |
| 179 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.79827818 |
| 180 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.79290646 |
| 181 | response to manganese ion (GO:0010042) | 2.78352652 |
| 182 | ethanol metabolic process (GO:0006067) | 2.77884226 |
| 183 | vitamin transmembrane transport (GO:0035461) | 2.75446687 |
| 184 | regulation of interleukin-12 production (GO:0032655) | 2.75052696 |
| 185 | desmosome organization (GO:0002934) | 2.71939267 |
| 186 | bile acid and bile salt transport (GO:0015721) | 2.68157234 |
| 187 | regulation of cholesterol homeostasis (GO:2000188) | 2.68046692 |
| 188 | citrulline metabolic process (GO:0000052) | 2.66029281 |
| 189 | thrombin receptor signaling pathway (GO:0070493) | 2.65595152 |
| 190 | chronic inflammatory response (GO:0002544) | 2.65118345 |
| 191 | glucocorticoid biosynthetic process (GO:0006704) | 2.64956186 |
| 192 | negative regulation of myotube differentiation (GO:0010832) | 2.64297065 |
| 193 | regulation of necrotic cell death (GO:0010939) | 2.62935201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.54879360 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.99355629 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.80629118 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.34572775 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.16128905 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36860960 |
| 7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.36831814 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.25479499 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00102507 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94941149 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.88523606 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.86004278 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64234849 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.54122858 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48206339 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.39946310 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32354070 |
| 18 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31236865 |
| 19 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.26623551 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25554766 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24790348 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16544198 |
| 23 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.15472445 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13080057 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08233982 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.95538506 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95112054 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94211272 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78149165 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74678562 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74228491 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73141221 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66989930 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60244802 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59577417 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59413100 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55674604 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.53939319 |
| 39 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.51214761 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51010806 |
| 41 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.44693369 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43092022 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42922362 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40343707 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38822665 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37080923 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36182829 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34946480 |
| 49 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.34424524 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33195155 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32990242 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31943038 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31489385 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31173346 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.30144476 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29074353 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29039496 |
| 58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.27050567 |
| 59 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24235435 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23834026 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20903727 |
| 62 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20823331 |
| 63 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20365418 |
| 64 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.19951277 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19421874 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.18690456 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16614462 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16332171 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13409431 |
| 70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12739336 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12581451 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12014050 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10524710 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10097582 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07920938 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07491201 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05921827 |
| 78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05710407 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04637323 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03911324 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03091065 |
| 82 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.02914424 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02682752 |
| 84 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02453602 |
| 85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00839166 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99959835 |
| 87 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.98764320 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98629895 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97071322 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96496219 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96471965 |
| 92 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96127520 |
| 93 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95731728 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95296865 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95108016 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93715052 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93714654 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93665559 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 0.93426258 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92197494 |
| 101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92063183 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91231278 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90568335 |
| 104 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90504224 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90197221 |
| 106 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90178354 |
| 107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90157921 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90135537 |
| 109 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89697228 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89614853 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88197897 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88197897 |
| 113 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87893564 |
| 114 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87880026 |
| 115 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86864734 |
| 116 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86714954 |
| 117 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.86642034 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86235361 |
| 119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85839269 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85021123 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84058126 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83727743 |
| 123 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82886853 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82094794 |
| 125 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81892193 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81864619 |
| 127 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81285123 |
| 128 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.81106002 |
| 129 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.80954433 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.80868242 |
| 131 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80842676 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.80347571 |
| 133 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79845780 |
| 134 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79673222 |
| 135 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.79299292 |
| 136 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.79299292 |
| 137 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.79299292 |
| 138 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78956662 |
| 139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78670886 |
| 140 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.78646633 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78567498 |
| 142 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.78443106 |
| 143 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.78164773 |
| 144 | UTX_26944678_Chip-Seq_JUKART_Human | 0.77957917 |
| 145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77902154 |
| 146 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77902154 |
| 147 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77659161 |
| 148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.76901481 |
| 149 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.76554737 |
| 150 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76287299 |
| 151 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75018327 |
| 152 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.74907707 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74844907 |
| 154 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.74810904 |
| 155 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74356124 |
| 156 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74184421 |
| 157 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.73921887 |
| 158 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73465227 |
| 159 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73388387 |
| 160 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.72942536 |
| 161 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72892684 |
| 162 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72620008 |
| 163 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72303183 |
| 164 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.72220542 |
| 165 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72197999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.96600279 |
| 2 | MP0009379_abnormal_foot_pigmentation | 5.24783412 |
| 3 | MP0003303_peritoneal_inflammation | 5.01977445 |
| 4 | MP0009785_altered_susceptibility_to | 4.18136492 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.96011562 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.89594710 |
| 7 | MP0004510_myositis | 3.78648788 |
| 8 | MP0006082_CNS_inflammation | 3.55355956 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.53293952 |
| 10 | MP0003724_increased_susceptibility_to | 3.49430316 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 3.40234949 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 3.39144495 |
| 13 | MP0003436_decreased_susceptibility_to | 3.22194125 |
| 14 | MP0000685_abnormal_immune_system | 2.96117106 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.91887026 |
| 16 | * MP0005025_abnormal_response_to | 2.90740918 |
| 17 | * MP0001790_abnormal_immune_system | 2.88245434 |
| 18 | * MP0005387_immune_system_phenotype | 2.88245434 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.84072595 |
| 20 | MP0002254_reproductive_system_inflammat | 2.82799657 |
| 21 | * MP0005000_abnormal_immune_tolerance | 2.71231230 |
| 22 | * MP0002419_abnormal_innate_immunity | 2.63628235 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.59633657 |
| 24 | MP0003866_abnormal_defecation | 2.54896224 |
| 25 | MP0000566_synostosis | 2.35316007 |
| 26 | MP0004147_increased_porphyrin_level | 2.35188887 |
| 27 | * MP0002452_abnormal_antigen_presenting | 2.24931719 |
| 28 | MP0005365_abnormal_bile_salt | 2.20077203 |
| 29 | * MP0002723_abnormal_immune_serum | 2.19207021 |
| 30 | * MP0001800_abnormal_humoral_immune | 2.17483127 |
| 31 | MP0005409_darkened_coat_color | 2.15235933 |
| 32 | MP0000477_abnormal_intestine_morphology | 2.14572704 |
| 33 | * MP0004947_skin_inflammation | 2.12333987 |
| 34 | * MP0001533_abnormal_skeleton_physiology | 2.09918047 |
| 35 | MP0000490_abnormal_crypts_of | 2.01857154 |
| 36 | MP0003172_abnormal_lysosome_physiology | 2.01027733 |
| 37 | MP0005310_abnormal_salivary_gland | 1.98379734 |
| 38 | MP0000678_abnormal_parathyroid_gland | 1.96606747 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.93811073 |
| 40 | MP0009278_abnormal_bone_marrow | 1.90010034 |
| 41 | * MP0001819_abnormal_immune_cell | 1.88015294 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.86463122 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.82567257 |
| 44 | * MP0001845_abnormal_inflammatory_respons | 1.81313784 |
| 45 | MP0002098_abnormal_vibrissa_morphology | 1.80789491 |
| 46 | * MP0010155_abnormal_intestine_physiology | 1.79956665 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.77617651 |
| 48 | * MP0001664_abnormal_digestion | 1.73477976 |
| 49 | * MP0005671_abnormal_response_to | 1.73354905 |
| 50 | * MP0003448_altered_tumor_morphology | 1.73151831 |
| 51 | MP0001853_heart_inflammation | 1.72528646 |
| 52 | MP0009764_decreased_sensitivity_to | 1.72495334 |
| 53 | MP0009840_abnormal_foam_cell | 1.72317142 |
| 54 | MP0005381_digestive/alimentary_phenotyp | 1.68630339 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.65827461 |
| 56 | * MP0008469_abnormal_protein_level | 1.64394447 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.63798554 |
| 58 | * MP0003075_altered_response_to | 1.56661183 |
| 59 | MP0002405_respiratory_system_inflammati | 1.54282375 |
| 60 | * MP0000604_amyloidosis | 1.50521514 |
| 61 | * MP0005464_abnormal_platelet_physiology | 1.46544680 |
| 62 | * MP0000343_altered_response_to | 1.43673443 |
| 63 | * MP0004858_abnormal_nervous_system | 1.43520854 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.42980067 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.40337135 |
| 66 | MP0002796_impaired_skin_barrier | 1.40148566 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.37352021 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.35659395 |
| 69 | MP0003045_fibrosis | 1.35645768 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.34364235 |
| 71 | MP0004043_abnormal_pH_regulation | 1.31620298 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.31427375 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.30942106 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.30942106 |
| 75 | MP0002006_tumorigenesis | 1.30824055 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.28644760 |
| 77 | MP0000462_abnormal_digestive_system | 1.28304923 |
| 78 | * MP0000716_abnormal_immune_system | 1.26611942 |
| 79 | MP0003938_abnormal_ear_development | 1.25976307 |
| 80 | MP0000681_abnormal_thyroid_gland | 1.24751198 |
| 81 | * MP0009643_abnormal_urine_homeostasis | 1.24428317 |
| 82 | MP0005257_abnormal_intraocular_pressure | 1.23044702 |
| 83 | MP0003091_abnormal_cell_migration | 1.22039349 |
| 84 | MP0008260_abnormal_autophagy | 1.20046035 |
| 85 | MP0002166_altered_tumor_susceptibility | 1.18798998 |
| 86 | MP0001188_hyperpigmentation | 1.16694315 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 1.14819725 |
| 88 | MP0003868_abnormal_feces_composition | 1.12813043 |
| 89 | MP0001765_abnormal_ion_homeostasis | 1.12583739 |
| 90 | * MP0002998_abnormal_bone_remodeling | 1.12184262 |
| 91 | MP0002332_abnormal_exercise_endurance | 1.10595692 |
| 92 | * MP0002398_abnormal_bone_marrow | 1.09627638 |
| 93 | MP0000858_altered_metastatic_potential | 1.08974488 |
| 94 | MP0003566_abnormal_cell_adhesion | 1.08919451 |
| 95 | MP0001851_eye_inflammation | 1.07602209 |
| 96 | * MP0005166_decreased_susceptibility_to | 1.06724395 |
| 97 | * MP0005164_abnormal_response_to | 1.05841646 |
| 98 | MP0010329_abnormal_lipoprotein_level | 1.05680750 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 1.04680013 |
| 100 | MP0003878_abnormal_ear_physiology | 1.04680013 |
| 101 | MP0003879_abnormal_hair_cell | 1.03879866 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 1.03057607 |
| 103 | MP0003252_abnormal_bile_duct | 1.01316689 |
| 104 | MP0003315_abnormal_perineum_morphology | 1.00702297 |
| 105 | * MP0002429_abnormal_blood_cell | 0.98364243 |
| 106 | * MP0005332_abnormal_amino_acid | 0.97444777 |
| 107 | MP0003690_abnormal_glial_cell | 0.96986268 |
| 108 | MP0009763_increased_sensitivity_to | 0.96523270 |
| 109 | MP0001873_stomach_inflammation | 0.93019489 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.91965337 |
| 111 | MP0002933_joint_inflammation | 0.91663678 |
| 112 | * MP0002896_abnormal_bone_mineralization | 0.91503780 |
| 113 | MP0010030_abnormal_orbit_morphology | 0.89976893 |
| 114 | * MP0005390_skeleton_phenotype | 0.89229298 |
| 115 | * MP0005023_abnormal_wound_healing | 0.88790375 |
| 116 | MP0008004_abnormal_stomach_pH | 0.87794059 |
| 117 | MP0005083_abnormal_biliary_tract | 0.85446389 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.85250572 |
| 119 | MP0000689_abnormal_spleen_morphology | 0.84690717 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.83755837 |
| 121 | MP0001663_abnormal_digestive_system | 0.83316690 |
| 122 | MP0005451_abnormal_body_composition | 0.83225051 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.80760200 |
| 124 | MP0003183_abnormal_peptide_metabolism | 0.80360428 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78647030 |
| 126 | MP0003828_pulmonary_edema | 0.78397849 |
| 127 | MP0002822_catalepsy | 0.78178982 |
| 128 | * MP0002722_abnormal_immune_system | 0.76693688 |
| 129 | MP0009115_abnormal_fat_cell | 0.73188628 |
| 130 | MP0003186_abnormal_redox_activity | 0.71313349 |
| 131 | MP0000377_abnormal_hair_follicle | 0.69701075 |
| 132 | MP0005448_abnormal_energy_balance | 0.68215089 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.66608287 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.66491281 |
| 135 | MP0010678_abnormal_skin_adnexa | 0.66307314 |
| 136 | MP0000609_abnormal_liver_physiology | 0.65749469 |
| 137 | MP0001348_abnormal_lacrimal_gland | 0.65244808 |
| 138 | MP0002971_abnormal_brown_adipose | 0.65188438 |
| 139 | MP0003806_abnormal_nucleotide_metabolis | 0.64016726 |
| 140 | MP0003195_calcinosis | 0.63570656 |
| 141 | MP0005367_renal/urinary_system_phenotyp | 0.63550085 |
| 142 | MP0000516_abnormal_urinary_system | 0.63550085 |
| 143 | * MP0010307_abnormal_tumor_latency | 0.62682448 |
| 144 | MP0001958_emphysema | 0.62374258 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.61518064 |
| 146 | MP0003656_abnormal_erythrocyte_physiolo | 0.61488745 |
| 147 | MP0005501_abnormal_skin_physiology | 0.61176682 |
| 148 | * MP0000249_abnormal_blood_vessel | 0.60837544 |
| 149 | * MP0002136_abnormal_kidney_physiology | 0.59272178 |
| 150 | MP0001216_abnormal_epidermal_layer | 0.56991991 |
| 151 | MP0003283_abnormal_digestive_organ | 0.56975639 |
| 152 | MP0005165_increased_susceptibility_to | 0.55945990 |
| 153 | MP0005666_abnormal_adipose_tissue | 0.55706101 |
| 154 | * MP0003795_abnormal_bone_structure | 0.55632779 |
| 155 | * MP0002118_abnormal_lipid_homeostasis | 0.55593313 |
| 156 | MP0008438_abnormal_cutaneous_collagen | 0.55075255 |
| 157 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.54757024 |
| 158 | MP0001849_ear_inflammation | 0.54073904 |
| 159 | MP0003693_abnormal_embryo_hatching | 0.54007446 |
| 160 | MP0003646_muscle_fatigue | 0.53619287 |
| 161 | MP0001346_abnormal_lacrimal_gland | 0.53576628 |
| 162 | MP0000026_abnormal_inner_ear | 0.53381102 |
| 163 | MP0003718_maternal_effect | 0.51204446 |
| 164 | * MP0001756_abnormal_urination | 0.49869133 |
| 165 | * MP0005319_abnormal_enzyme/_coenzyme | 0.49268940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malnutrition (HP:0004395) | 6.88710121 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.05809094 |
| 3 | Chronic otitis media (HP:0000389) | 5.80659113 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.59913754 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.27072193 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.97245104 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.74243934 |
| 8 | Ileus (HP:0002595) | 4.55278109 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.53957892 |
| 10 | Nasal polyposis (HP:0100582) | 4.52552786 |
| 11 | Chronic diarrhea (HP:0002028) | 4.52551583 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47288945 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.41383191 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.35186504 |
| 15 | Glomerulonephritis (HP:0000099) | 4.33217337 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 4.16419949 |
| 17 | Orchitis (HP:0100796) | 4.13297692 |
| 18 | Stomatitis (HP:0010280) | 4.11376593 |
| 19 | Tetraparesis (HP:0002273) | 4.06452103 |
| 20 | Decreased circulating renin level (HP:0003351) | 3.97425544 |
| 21 | Myositis (HP:0100614) | 3.94134290 |
| 22 | Interstitial pulmonary disease (HP:0006530) | 3.83516511 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.81664460 |
| 24 | Recurrent skin infections (HP:0001581) | 3.74757762 |
| 25 | Hyperactive renin-angiotensin system (HP:0000841) | 3.71790515 |
| 26 | Alkalosis (HP:0001948) | 3.71241829 |
| 27 | Gingivitis (HP:0000230) | 3.70983651 |
| 28 | Abnormality of complement system (HP:0005339) | 3.70864436 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.64854739 |
| 30 | Optic neuritis (HP:0100653) | 3.64854739 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.63496841 |
| 32 | Complement deficiency (HP:0004431) | 3.60023486 |
| 33 | Increased IgM level (HP:0003496) | 3.59622974 |
| 34 | Villous atrophy (HP:0011473) | 3.48203195 |
| 35 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.48203195 |
| 36 | Proximal tubulopathy (HP:0000114) | 3.47300008 |
| 37 | Widely patent fontanelles and sutures (HP:0004492) | 3.45367765 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.41208725 |
| 39 | Pustule (HP:0200039) | 3.41158225 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.36630889 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.36630889 |
| 42 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.34123016 |
| 43 | Vasculitis (HP:0002633) | 3.32260049 |
| 44 | Fat malabsorption (HP:0002630) | 3.31540498 |
| 45 | Metabolic alkalosis (HP:0200114) | 3.30700859 |
| 46 | Right ventricular cardiomyopathy (HP:0011663) | 3.30116803 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 3.23848561 |
| 48 | Premature loss of primary teeth (HP:0006323) | 3.23644864 |
| 49 | Hypobetalipoproteinemia (HP:0003563) | 3.22955663 |
| 50 | Chronic sinusitis (HP:0011109) | 3.21971867 |
| 51 | Recurrent viral infections (HP:0004429) | 3.21868103 |
| 52 | Abnormality of renin-angiotensin system (HP:0000847) | 3.19214051 |
| 53 | Prostate neoplasm (HP:0100787) | 3.18700247 |
| 54 | Basal ganglia calcification (HP:0002135) | 3.13243030 |
| 55 | Acanthocytosis (HP:0001927) | 3.09124524 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 3.07653417 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 3.03584862 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.97387614 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.96774303 |
| 60 | Loss of speech (HP:0002371) | 2.95589896 |
| 61 | Periodontitis (HP:0000704) | 2.92824299 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.92801550 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.92780222 |
| 64 | Flat acetabular roof (HP:0003180) | 2.90639949 |
| 65 | Recurrent bronchitis (HP:0002837) | 2.86433343 |
| 66 | Thick nail (HP:0001805) | 2.86263920 |
| 67 | Hydroxyprolinuria (HP:0003080) | 2.84188988 |
| 68 | Abnormality of proline metabolism (HP:0010907) | 2.84188988 |
| 69 | Abdominal distention (HP:0003270) | 2.80028133 |
| 70 | Hematochezia (HP:0002573) | 2.78380283 |
| 71 | Pigmentary retinal degeneration (HP:0001146) | 2.78094008 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77461609 |
| 73 | Obstructive lung disease (HP:0006536) | 2.77461609 |
| 74 | Porencephaly (HP:0002132) | 2.72626891 |
| 75 | Abnormal tarsal ossification (HP:0008369) | 2.71137675 |
| 76 | Nausea (HP:0002018) | 2.70271129 |
| 77 | Axonal loss (HP:0003447) | 2.67566530 |
| 78 | Wide cranial sutures (HP:0010537) | 2.67274202 |
| 79 | Increased IgE level (HP:0003212) | 2.66066457 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.63862171 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.63862171 |
| 82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.63862171 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.60924109 |
| 84 | Nephrolithiasis (HP:0000787) | 2.60735988 |
| 85 | Urticaria (HP:0001025) | 2.56823226 |
| 86 | Neoplasm of head and neck (HP:0012288) | 2.51741585 |
| 87 | Esophageal neoplasm (HP:0100751) | 2.51741585 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.50826573 |
| 89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.49535124 |
| 90 | Vertebral compression fractures (HP:0002953) | 2.49534788 |
| 91 | Emphysema (HP:0002097) | 2.48763740 |
| 92 | Abnormality of urine glucose concentration (HP:0011016) | 2.47766109 |
| 93 | Glycosuria (HP:0003076) | 2.47766109 |
| 94 | Disinhibition (HP:0000734) | 2.46616819 |
| 95 | Hyperuricemia (HP:0002149) | 2.45590535 |
| 96 | Increased purine levels (HP:0004368) | 2.45590535 |
| 97 | Myocardial infarction (HP:0001658) | 2.42794169 |
| 98 | Abnormality of vitamin metabolism (HP:0100508) | 2.42604443 |
| 99 | Pili torti (HP:0003777) | 2.38398815 |
| 100 | Hyperglycinuria (HP:0003108) | 2.37803307 |
| 101 | Osteomyelitis (HP:0002754) | 2.37319220 |
| 102 | Cellulitis (HP:0100658) | 2.37279973 |
| 103 | Delayed epiphyseal ossification (HP:0002663) | 2.35709223 |
| 104 | Hyperparathyroidism (HP:0000843) | 2.35624546 |
| 105 | Hyperammonemia (HP:0001987) | 2.35608575 |
| 106 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.32776067 |
| 107 | Thin bony cortex (HP:0002753) | 2.31918909 |
| 108 | Increased serum ferritin (HP:0003281) | 2.29940855 |
| 109 | Confusion (HP:0001289) | 2.29282557 |
| 110 | Hyperphosphatemia (HP:0002905) | 2.28441996 |
| 111 | Cerebral palsy (HP:0100021) | 2.26612477 |
| 112 | Autoimmune hemolytic anemia (HP:0001890) | 2.25165868 |
| 113 | Dysostosis multiplex (HP:0000943) | 2.24628958 |
| 114 | Frequent falls (HP:0002359) | 2.22761811 |
| 115 | Posterior subcapsular cataract (HP:0007787) | 2.21321581 |
| 116 | Hypophosphatemia (HP:0002148) | 2.20750998 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 2.20538053 |
| 118 | Bone pain (HP:0002653) | 2.20498168 |
| 119 | Arterial thrombosis (HP:0004420) | 2.20141145 |
| 120 | Focal segmental glomerulosclerosis (HP:0000097) | 2.19722317 |
| 121 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.19359628 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19335621 |
| 123 | Mucopolysacchariduria (HP:0008155) | 2.19335621 |
| 124 | Esophageal varix (HP:0002040) | 2.19302029 |
| 125 | Gastrointestinal infarctions (HP:0005244) | 2.16493552 |
| 126 | Hemoptysis (HP:0002105) | 2.16078083 |
| 127 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15950190 |
| 128 | Abnormality of glycine metabolism (HP:0010895) | 2.15950190 |
| 129 | Hepatosplenomegaly (HP:0001433) | 2.14506222 |
| 130 | Hypotension (HP:0002615) | 2.13481476 |
| 131 | Abnormality of the 1st metacarpal (HP:0010009) | 2.13375429 |
| 132 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11532596 |
| 133 | Peritonitis (HP:0002586) | 2.10864717 |
| 134 | Partial duplication of thumb phalanx (HP:0009944) | 2.07483108 |
| 135 | Cupped ribs (HP:0000887) | 2.07212052 |
| 136 | Skin ulcer (HP:0200042) | 2.07002829 |
| 137 | Leukocytosis (HP:0001974) | 2.04116139 |
| 138 | Pancreatitis (HP:0001733) | 2.04060098 |
| 139 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03155174 |
| 140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03155174 |
| 141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03155174 |
| 142 | Protuberant abdomen (HP:0001538) | 2.02498355 |
| 143 | Abnormal hair laboratory examination (HP:0003328) | 2.01041866 |
| 144 | Gingival bleeding (HP:0000225) | 2.00535310 |
| 145 | Anorexia (HP:0002039) | 2.00315358 |
| 146 | Abnormal biliary tract morphology (HP:0012440) | 1.99185997 |
| 147 | Inflammation of the large intestine (HP:0002037) | 1.97957241 |
| 148 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97824297 |
| 149 | Ventricular fibrillation (HP:0001663) | 1.97541334 |
| 150 | Abnormality of the pericardium (HP:0001697) | 1.97317938 |
| 151 | Abnormality of magnesium homeostasis (HP:0004921) | 1.96981097 |
| 152 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.94540335 |
| 153 | Abnormality of purine metabolism (HP:0004352) | 1.94114771 |
| 154 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93213738 |
| 155 | Osteolytic defects of the hand bones (HP:0009699) | 1.91828801 |
| 156 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91828801 |
| 157 | Facial shape deformation (HP:0011334) | 1.91408207 |
| 158 | Potter facies (HP:0002009) | 1.91408207 |
| 159 | Abnormality of iron homeostasis (HP:0011031) | 1.91175203 |
| 160 | Biliary tract neoplasm (HP:0100574) | 1.90976356 |
| 161 | Nephritis (HP:0000123) | 1.90630145 |
| 162 | Gastrointestinal inflammation (HP:0004386) | 1.90062574 |
| 163 | Recurrent pneumonia (HP:0006532) | 1.89369774 |
| 164 | Plantar hyperkeratosis (HP:0007556) | 1.89328493 |
| 165 | Spastic tetraparesis (HP:0001285) | 1.89302496 |
| 166 | Broad metatarsal (HP:0001783) | 1.88641451 |
| 167 | Micronodular cirrhosis (HP:0001413) | 1.88584743 |
| 168 | Xanthomatosis (HP:0000991) | 1.88290495 |
| 169 | Intrahepatic cholestasis (HP:0001406) | 1.87598587 |
| 170 | Dicarboxylic aciduria (HP:0003215) | 1.85813443 |
| 171 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85813443 |
| 172 | Growth hormone excess (HP:0000845) | 1.84661324 |
| 173 | Rectal prolapse (HP:0002035) | 1.83933225 |
| 174 | Lower limb hyperreflexia (HP:0002395) | 1.83671122 |
| 175 | Reticulocytosis (HP:0001923) | 1.83049968 |
| 176 | Progressive visual loss (HP:0000529) | 1.82465980 |
| 177 | Colitis (HP:0002583) | 1.82366731 |
| 178 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80375233 |
| 179 | Curly hair (HP:0002212) | 1.75538278 |
| 180 | Abnormality of carpal bone ossification (HP:0006257) | 1.75461521 |
| 181 | Goiter (HP:0000853) | 1.74372659 |
| 182 | Hypokalemia (HP:0002900) | 1.74137920 |
| 183 | Flattened epiphyses (HP:0003071) | 1.72606727 |
| 184 | Gastrointestinal dysmotility (HP:0002579) | 1.72135158 |
| 185 | Gastrointestinal stroma tumor (HP:0100723) | 1.71714603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 4.50701526 |
| 2 | ACVR1B | 4.49922732 |
| 3 | TYK2 | 4.26015938 |
| 4 | MAP3K14 | 4.25621328 |
| 5 | PBK | 3.89294907 |
| 6 | IKBKE | 3.89199585 |
| 7 | IRAK3 | 3.22480992 |
| 8 | EPHB2 | 2.99994638 |
| 9 | ERN1 | 2.95941387 |
| 10 | BLK | 2.80029118 |
| 11 | RIPK4 | 2.78715137 |
| 12 | STK39 | 2.78334557 |
| 13 | EPHB1 | 2.65874935 |
| 14 | EPHA4 | 2.65516797 |
| 15 | JAK3 | 2.55506000 |
| 16 | JAK1 | 2.52164337 |
| 17 | FGFR4 | 2.48051645 |
| 18 | KIT | 2.46198586 |
| 19 | IRAK4 | 2.26959836 |
| 20 | MET | 2.16255845 |
| 21 | OXSR1 | 2.13393057 |
| 22 | MAP3K13 | 2.00102302 |
| 23 | EPHA3 | 1.94936012 |
| 24 | IKBKB | 1.92510361 |
| 25 | MST4 | 1.89185117 |
| 26 | STK24 | 1.78141530 |
| 27 | CSK | 1.67972656 |
| 28 | FGFR3 | 1.62296452 |
| 29 | FGR | 1.56604743 |
| 30 | MATK | 1.56125682 |
| 31 | PIM2 | 1.49747733 |
| 32 | CHUK | 1.45452597 |
| 33 | LATS1 | 1.44837057 |
| 34 | CDC42BPA | 1.43912312 |
| 35 | BMX | 1.43484598 |
| 36 | PRPF4B | 1.30585275 |
| 37 | PTK6 | 1.27296453 |
| 38 | MST1R | 1.27184172 |
| 39 | JAK2 | 1.16496608 |
| 40 | NME1 | 1.11773545 |
| 41 | MAP4K1 | 1.10510256 |
| 42 | RIPK1 | 1.06559605 |
| 43 | RPS6KA4 | 1.05286746 |
| 44 | MAP3K12 | 1.02677670 |
| 45 | PDGFRA | 1.02157248 |
| 46 | HCK | 1.00766798 |
| 47 | ARAF | 0.99206239 |
| 48 | TAOK3 | 0.95161499 |
| 49 | MAP3K10 | 0.94308554 |
| 50 | SYK | 0.91799332 |
| 51 | TESK2 | 0.90018758 |
| 52 | MAP3K5 | 0.89246754 |
| 53 | CDK19 | 0.89157747 |
| 54 | FGFR2 | 0.88988729 |
| 55 | ABL2 | 0.87294678 |
| 56 | LCK | 0.87169512 |
| 57 | DDR2 | 0.85453179 |
| 58 | ERBB2 | 0.85292344 |
| 59 | LMTK2 | 0.84423778 |
| 60 | STK10 | 0.83631156 |
| 61 | ZAP70 | 0.83185177 |
| 62 | LYN | 0.81238733 |
| 63 | DMPK | 0.80120991 |
| 64 | DYRK1B | 0.79390569 |
| 65 | FES | 0.79350752 |
| 66 | MAP3K1 | 0.77374597 |
| 67 | MAP3K9 | 0.77180947 |
| 68 | KSR2 | 0.76803752 |
| 69 | MAP3K2 | 0.76152217 |
| 70 | EGFR | 0.75707429 |
| 71 | PRKG2 | 0.75519121 |
| 72 | MYLK | 0.73016516 |
| 73 | NME2 | 0.72373153 |
| 74 | TXK | 0.70268824 |
| 75 | TYRO3 | 0.69307587 |
| 76 | ALK | 0.68522331 |
| 77 | IRAK1 | 0.67349172 |
| 78 | PDK2 | 0.67171925 |
| 79 | MAP3K7 | 0.67105287 |
| 80 | MARK3 | 0.64349725 |
| 81 | TIE1 | 0.64009701 |
| 82 | GRK6 | 0.59694148 |
| 83 | STK38L | 0.57083567 |
| 84 | TTN | 0.56919257 |
| 85 | ABL1 | 0.55344024 |
| 86 | MAP3K11 | 0.53351645 |
| 87 | FRK | 0.53202165 |
| 88 | LRRK2 | 0.52433951 |
| 89 | CAMK2D | 0.52047973 |
| 90 | TNIK | 0.51236146 |
| 91 | CSF1R | 0.51135342 |
| 92 | TESK1 | 0.50005898 |
| 93 | TRIB3 | 0.48038443 |
| 94 | TGFBR2 | 0.47997855 |
| 95 | MOS | 0.47227725 |
| 96 | AKT3 | 0.45123451 |
| 97 | EIF2AK2 | 0.45022127 |
| 98 | STK4 | 0.44809930 |
| 99 | FYN | 0.44777789 |
| 100 | SMG1 | 0.44415786 |
| 101 | NLK | 0.44018812 |
| 102 | PDGFRB | 0.42823094 |
| 103 | PRKCD | 0.42427036 |
| 104 | DAPK3 | 0.41127448 |
| 105 | YES1 | 0.40959311 |
| 106 | PRKACG | 0.40868296 |
| 107 | PIM1 | 0.40183542 |
| 108 | PRKCA | 0.37569490 |
| 109 | PRKAA2 | 0.37482389 |
| 110 | EPHA2 | 0.37466012 |
| 111 | SIK3 | 0.36739602 |
| 112 | CDK6 | 0.36633841 |
| 113 | LATS2 | 0.35710696 |
| 114 | ERBB4 | 0.35586494 |
| 115 | BTK | 0.34866334 |
| 116 | MAP2K2 | 0.34488784 |
| 117 | FER | 0.33436020 |
| 118 | MAP2K6 | 0.32246593 |
| 119 | PTK2 | 0.32164398 |
| 120 | MAP3K3 | 0.31738157 |
| 121 | MAPKAPK2 | 0.31056960 |
| 122 | WNK4 | 0.30859227 |
| 123 | PRKCZ | 0.30775754 |
| 124 | DAPK2 | 0.30070640 |
| 125 | * SRC | 0.29926554 |
| 126 | PDPK1 | 0.29336342 |
| 127 | PKN2 | 0.28483616 |
| 128 | TAOK1 | 0.27571436 |
| 129 | KDR | 0.27170243 |
| 130 | CASK | 0.25852287 |
| 131 | PAK4 | 0.25713674 |
| 132 | STK3 | 0.25603343 |
| 133 | MAPK11 | 0.24900339 |
| 134 | IGF1R | 0.24224610 |
| 135 | PRKCQ | 0.24217899 |
| 136 | CAMK2G | 0.24170635 |
| 137 | PIK3CA | 0.23783596 |
| 138 | MAPK4 | 0.23177892 |
| 139 | RET | 0.22739459 |
| 140 | MELK | 0.22738754 |
| 141 | BMPR2 | 0.21555449 |
| 142 | NEK9 | 0.21347236 |
| 143 | PTK2B | 0.20647183 |
| 144 | PLK2 | 0.19900968 |
| 145 | RPS6KA1 | 0.19539329 |
| 146 | SIK1 | 0.19333511 |
| 147 | INSR | 0.18905122 |
| 148 | PDK1 | 0.18307584 |
| 149 | MAPK7 | 0.17905677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.44038163 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.06002508 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.12765107 |
| 4 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.00195425 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.88190196 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.87274648 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.64905783 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.53410358 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53106425 |
| 10 | Influenza A_Homo sapiens_hsa05164 | 2.47027605 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43918936 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.37274645 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30979877 |
| 14 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.27327180 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.22423497 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.21966478 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.20415104 |
| 18 | Malaria_Homo sapiens_hsa05144 | 2.14129873 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 2.08447275 |
| 20 | * Pertussis_Homo sapiens_hsa05133 | 2.04042639 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.03103506 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.01669803 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.00075489 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.94321982 |
| 25 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94085633 |
| 26 | * Tuberculosis_Homo sapiens_hsa05152 | 1.89104849 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81651012 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.81646927 |
| 29 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.76601337 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.76409869 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75643155 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.74493668 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69094656 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68218706 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.64996397 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62544063 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.61745012 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56582971 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49528649 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43680425 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.43443325 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.41287929 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36665677 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.33152619 |
| 45 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31884583 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27715817 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26864714 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24557187 |
| 49 | * Salmonella infection_Homo sapiens_hsa05132 | 1.24099949 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24042053 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23461490 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 1.22267888 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22094832 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20723887 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.20357598 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 1.19232642 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.17795150 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17705333 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17165035 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16922459 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15523086 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 1.14507412 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12926649 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12110607 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.10103163 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09325649 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07312174 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06970391 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06611909 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06526272 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06426222 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05856405 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05131524 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99868836 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98141650 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97722736 |
| 77 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97155532 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95311924 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93584682 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92413769 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.92005531 |
| 82 | * Amoebiasis_Homo sapiens_hsa05146 | 0.90455771 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90247640 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89125072 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86781822 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86477845 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84251933 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81262258 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80300949 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79223379 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75517476 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75472159 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75256086 |
| 94 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72666890 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71147162 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71046106 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70439452 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69291278 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68586910 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68373583 |
| 101 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.65054392 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63156299 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61806967 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61734752 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60470581 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58393218 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53434899 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.51650408 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50533337 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.49859346 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49460286 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48934937 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48894792 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46190533 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43913728 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43335807 |
| 117 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43218517 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42426915 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41835782 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.41451877 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39990808 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38394003 |
| 123 | Renin secretion_Homo sapiens_hsa04924 | 0.38005468 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37529379 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.36186653 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36042821 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35829745 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35537232 |
| 129 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34967479 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34872879 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34194988 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33433625 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32457509 |
| 134 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30229291 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29424735 |
| 136 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28991785 |
| 137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28558361 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28362329 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26832113 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.22455040 |
| 141 | ABC transporters_Homo sapiens_hsa02010 | 0.22020310 |
| 142 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.21733529 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20941542 |
| 144 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20494604 |
| 145 | Endocytosis_Homo sapiens_hsa04144 | 0.20477380 |
| 146 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20326279 |
| 147 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18003734 |
| 148 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17506503 |
| 149 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.17389683 |
| 150 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.17008600 |
| 151 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.15745809 |
| 152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14729154 |
| 153 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12393377 |
| 154 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.10545686 |
| 155 | * Peroxisome_Homo sapiens_hsa04146 | 0.08934199 |
| 156 | Carbon metabolism_Homo sapiens_hsa01200 | 0.08894807 |

